Scandinavian Medical Solutions AS (SMSMED) — Capital Reinvestment Ratio
Scandinavian Medical Solutions AS (SMSMED) has a Capital Reinvestment Ratio of 0.85x as of September 2024, meaning it reinvests 1% of its operating cash flow (Dkr17.86 Million) in capital expenditures (Dkr15.13 Million). See Scandinavian Medical Solutions AS (SMSMED) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Scandinavian Medical Solutions AS Capital Reinvestment Ratio (2020–2024)
This chart tracks Scandinavian Medical Solutions AS's Capital Reinvestment Ratio across 3 annual periods. Check SMSMED cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Scandinavian Medical Solutions AS (2020–2024)
Year-by-year Capital Reinvestment Ratio for Scandinavian Medical Solutions AS from 2020 to 2024. For live market cap and broader valuation context, see SMSMED stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (DKK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 5.44x | Dkr3.39 Million | Dkr18.47 Million | ▲ +438250430.7% |
| 2021 | 0.00x | Dkr4.02 Million | Dkr5.00 | ▼ -100.0% |
| 2020 | 1.47x | Dkr9.38 Million | Dkr13.76 Million | — |